  See all
 |
Articles: Drug Trials |
Prior Articles
ImmunoGen Announces Encouraging New Clinical Data with the Company's IMGN901 Compound in the Treatment of Small-Cell Lung Cancer
ImmunoGen, Inc., 08/04/09
Free full text
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa
Amgen, 08/04/09
Free full text
Shire Reports Positive Results from First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions with FDA
Shire, 08/04/09 A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion
BMC Clinical Pharmacology, 08/03/09
Free full text
Second Phase III Study Showed Lucentis Improved Vision in Patients with Retinal Vein Occlusion
Genentech, 07/31/09
Free full text
Beta-Receptor Selectivity of Carvedilol and Metoprolol Succinate in Patients with Heart Failure (SELECT Trial): A Randomized Dose-Ranging Trial
Pharmacotherapy, 07/31/09 Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of hydroxyurea
Pediatric Blood & Cancer, 07/30/09 Pralidoxime in Acute Organophosphorus Insecticide Poisoning--A Randomised Controlled Trial
PLoS Medicine, 07/30/09
Free full text
Report Shows New York City Companies Playing Key Role
In Development of New Medicines for Wide Range of Diseases
PhRMA, 07/30/09
Free full text
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/30/09
Free full text
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Dendreon Coproration, 07/30/09
Free full text
ARIAD Announces Preliminary Data from Two Ongoing Clinical Trials of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Targeted Drugs
ARIAD Pharmaceuticals, 07/29/09
Free full text
Sildenafil trial stopped 1 year early because of safety concerns
American Pharmacists Association, 07/29/09
Free full text
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/29/09
Free full text
An Update of Recent Trials with Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes
Journal of Pharmacy Technology, 07/28/09 Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/28/09
Free full text
Economic analysis of alvimopan in North American Phase III efficacy trials
American Journal of Health-System Pharmacy, 07/28/09 Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/27/09
Free full text
Recruitment completed in arzerra (ofatumumab) phase ii study in relapsed dlbcl
Genmab, 07/27/09
Free full text
Relations Between In-Treatment and Follow-Up Abstinence Among Cocaine-Dependent Homeless Persons in Three Clinical Trials
Experimental and Clinical Psychopharmacology, 07/24/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
